The natural olive constituent oleuropein induces nutritional cardioprotection in normal and cholesterol-fed rabbits: Comparison with preconditioning

Planta Medica

Volumn 81, Issue 8, 2015, Pages 655-663

  Andreadou, Ioanna ^a   Benaki, Dimitra ^a   Efentakis, Panagiotis ^a   Bibli, Sofia Iris ^a   Milioni, Alkistis Ioanna ^a   Papachristodoulou, Anastasia ^a   Zoga, Anastasia ^b   Skaltsounis, Alexios Leandros ^a   Mikros, Emmanuel ^a   Iliodromitis, Efstathios K ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

metabonomics; Olea europaea; Oleaceae; oleuropein; oxidative stress; preconditioning; signaling molecules

Indexed keywords

3 NITROTYROSINE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXANTHINE; INOSINE; MALONALDEHYDE; OLEUROPEIN; PHOSPHATIDYLINOSITOL 3 KINASE; STAT3 PROTEIN; 3-NITROTYROSINE; IRIDOID; PROTECTIVE AGENT; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CHOLESTEROL DIET; CONTROLLED STUDY; EXPERIMENTAL RABBIT; HEART INFARCTION PREVENTION; HEART MUSCLE BIOPSY; HEART PROTECTION; HYPERCHOLESTEROLEMIA; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; MALE; METABOLOME; NITROSATIVE STRESS; NONHUMAN; OLIVE; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; PURINE METABOLISM; REPERFUSION INJURY; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CARDIAC MUSCLE; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; OLIVE TREE; RABBIT; SIGNAL TRANSDUCTION;

ANIMALIA; OLEA EUROPAEA; OLEACEAE; ORYCTOLAGUS CUNICULUS;

ANIMALS; CHOLESTEROL; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; IRIDOIDS; MALE; MALONDIALDEHYDE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OLEA; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTECTIVE AGENTS; RABBITS; SIGNAL TRANSDUCTION; TYROSINE;

EID: 84946240687     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1383306     Document Type: Article

References (56)

1. Omar S. H. Oleuropein in olive and its pharmacological effects. Sci Pharm: 2010; 78 133 154
2. Masella R., Varì R., D'Archivio M., Di Benedetto R. Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes. J Nutr: 2004; 134 785 791
3. Andreadou I., Sigala F., Iliodromitis E. K., Papaefthimiou M., Sigalas C., Aligiannis N., Savvari P., Gorgoulis V., Papalabros E., Kremastinos D. T. Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress. J Mol Cell Cardiol: 2007; 42 549 558
4. Andreadou I., Papaefthimiou M., Zira A., Constantinou M., Sigala F., Skaltsounis A. L., Tsantili-Kakoulidou A., Iliodromitis E. K., Kremastinos D. T., Mikros E. Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein. NMR Biomed: 2009; 22 585 592
5. Andreadou I., Mikros E., Ioannidis K., Sigala F., Naka K., Kostidis S., Farmakis D., Tenta R., Kavantzas N., Bibli S. I., Gikas E., Skaltsounis L., Kremastinos D. Th, Iliodromitis E. K. Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism. J Mol Cell Cardiol: 2014; 69 4 16
6. DellE'Agli M., Maschi O., Galli G. V., Fagnani R., Dal Cero E., Caruso D., Bosisio E. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase. Br J Nutr: 2008; 99 945 951
7. Manna C., Migliardi V., Golino P., Scognamiglio A., Galletti P., Chiariello M., Zappia V. Oleuropein prevents oxidative myocardial injury induced by ischemia and reperfusion. J Nutr Biochem: 2004; 15 461 466
8. Andreadou I., Iliodromitis E. K., Mikros E., Constantinou M., Agalias A., Magiatis P., Skaltsounis A. L., Kamber E., Tsantili-Kakoulidou A., Kremastinos D. T. The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J Nutr: 2006; 136 2213 2219
9. Hausenloy D. J., Yellon D. M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Investig: 2013; 123 92 100
10. Parlakpinar H., Orum M. H., Sagir M. Pathophysiology of myocardial ischemia reperfusion injury: a review. Med Sci: 2013; 935 954
11. Murry C. E., Jennings R. B., Reimer K. A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation: 1986; 74 1124 1136
12. Heusch G. Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction? Eur Heart J: 2012; 33 13 15
13. Ardehali H. Signaling mechanisms in ischemic preconditioning: interaction of PKC ε and mitoKATP in the inner membrane of mitochondria. Circulation Res: 2006; 99 798 800
14. Hausenloy D. J., Yellon D. M. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis: 2009; 204 334 341
15. Nishino Y., Miura T., Miki T., Sakamoto J., Nakamura Y., Ikeda Y., Kobayashi H., Shimamoto K. Ischemic preconditioning activates AMPK in a PKC- dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc Res: 2004; 61 610 619
16. Young L. H. AMP-activated protein kinase conducts the ischemic stress response orchestra. Circulation: 2008; 117 832 840
17. Abdukeyum G., Owen A. J., McLennan P. L. Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning. J Nutr: 2008; 138 1902 1909
18. Renaud S., de Lorgeril M., Delaye J., Guidollet J., Jacquard F., Mamelle N., Martin J. L., Monjaud I., Salen P., Toubol P. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Nutr: 1995; 61 1360S 1367S
19. Widmer R. J., Freund M. A., Flammer A. J., Sexton J., Lennon R., Romani A., Mulinacci N., Vinceri F. F., Lerman L. O., Lerman A. Beneficial effects of polyphenol-rich olive oil in patients with early atherosclerosis. Eur J Nutr: 2013; 52 1223 1231
20. Baines C. P., Goto M., Downey J. M. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol: 1997; 29 207 216
21. Andreadou I., Iliodromitis E. K., Souridis V., Prokovas E., Kostidis S., Zoga A., Dagres N., Tsantili-Kakoulidou A., Kremastinos D. T., Mikros E., Anastasiou-Nana M. Investigating the effect of antioxidant treatment on the protective effect of preconditioning in anesthetized rabbits. J Cardiovasc Pharmacol: 2011; 58 609 616
22. Turan N., Csonska C., Csont T., Giricz Z., Fodor G., Bencsik P., Gyongyosi M., Cakici I., Ferdinandy P. The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts. Cardiovasc Res: 2006; 70 384 390
23. Tsovolas K., Iliodromitis E. K., Andreadou I., Zoga A., Demopoulou M., Iliodromitis K., Markantonis S. L., Kremastinos D. T. Acute administration of vitamin C abrogates protection from ischemic preconditioning in rabbits. Pharmacol Res: 2008; 57 283 289
24. Speroni E., Guerra M. C., Minghetti A., Crespi-Perellino N., Pasini P., Piazza F. Oleuropein evaluated in vitro and in vivo as an antioxidant. Phytother Res: 1998; 12 98 100
25. Schulz R., Cohen M. V, Behrends M., Downey J. M., Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res: 2001; 52 181 198
26. Oldenburg O., Qin Q., Krieg T., Yang X. M., Philipp S., Critz S. D., Cohen M. V., Downey J. M. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol: 2004; 286 H468 H476
27. Hausenloy D. J., Yellon D. M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res: 2004; 61 448 460
28. Hausenloy D. J., Tsang A., Mocanu M. M., Yellon D. M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol: 2004; 288 H971 H976
29. Xuan Y. T., Tang X. L., Qiu Y., Banerjee S., Takano H., Han H., Bolli R. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol: 2000; 279 H2360 H2371
30. Nandagopal K., Dawson T. M., Dawson V. L. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. JPET: 2001; 297 474 478
31. Smith R. M., Suleman N., Lacerda L., Opie L. H., Akira S., Chien K. R., Sack M. N. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res: 2004; 63 611 616
32. Cserepes B., Jancsó G., Gasz B., Rácz B., Ferenc A., Benkó L., Borsiczky B., Kürthy M., Ferencz S., Lantos J., Gál J., Arató E., Miseta A., Wéber G., Róth E. Cardioprotective action of urocortin in early pre- and postconditioning. Ann N Y Acad Sci: 2007; 1095 228 239
33. Bergeron R., Russell R. R., Young L. H., Ren J. M., Marcucci M., Lee A., Shulman G. I. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol: 1999; 276 E938 E944
34. Calvert J. W., Gundewr J. W., Jha S., Greer J. J., Bestermann W. H., Tian R., Lefer D. J. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes: 2008; 57 696 705
35. Lopaschuk G. D. AMP-activated protein kinase control of energy metabolism in the ischemic heart. Int J Obes: 2008; 32 S29 S35
36. Paiva M. A., Gonçalves L. M., Providência L. A., Davidson S. M., Yellon D. M., Mocanu M. M. Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction. Cardiovasc Drugs Ther: 2010; 24 25 32
37. Stein L. R., Imai S. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab: 2012; 23 420 428
38. Imai S. Dissecting systemic control of metabolism and aging in the NAD World: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett: 2011; 585 1657 1662
39. Hsu C. P., Oka S., Shao D., Hariharan N., Sadoshima J. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res: 2009; 105 481 491
40. Yamamoto T., Byun J., Zhai P., Ikeda Y., Oka S., Sadoshima J. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS ONE: 2014; 9 e98972
41. Fulco M., Cen Y., Zhao P., Hoffman E. P., McBurney M. W., Sauve A. A., Sartorelli V. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell: 2008; 14 661 673
42. Morrison A., Li J. PPAR-c and AMPK-advantageous targets for myocardial ischemia/reperfusion therapy. Biochem Pharmacol: 2011; 82 195 200
43. Monassier J. P. Reperfusion injury in acute myocardial infarction. From bench to cath lab. Part I: Basic considerations. Arch Card Dis: 2008; 101 491 500
44. 31P nuclear magnetic resonance study in swine. Crit Care Med: 1995; 23 733 739
45. Dyballa-Rukes N., Schuh C., Vogt H., Toma O., Schlack W. S., Weber N. C., Metzger S. In vivo desflurane preconditioning evokes dynamic alterations of metabolic proteins in the heart - proteomic insights strengthen the link between bioenergetics and cardioprotection. Cell Physiol Biochem: 2014; 33 967 981
46. Orbetzova V., Kiprov D. Effect of cholesterol-rich diet on the content of nicotinamide nucleotides, adenine nucleotides and acetyl-CoA in the liver, the vascular wall and the kidney of spontaneously hypertensive rats [SHR]. Cor Vasa: 1979; 21 353 362
47. Hardie D. G. The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci: 2004; 117 5479 5487
48. Svobodova M., Andreadou I., Skaltsounis A. L., Kopecky J., Flachs P. Oleuropein as an inhibitor of peroxisome proliferator-activated receptor gamma. Genes & Nutrition: 2014; 9 376
49. Quaranta G., Rotundo V. Economic and commercial prospects for olive oil in view of the changes in the common market organisation (CMO) (Part one). Olivae: 2000; 91 20 24
50. Andreadou I., Farmakis D., Prokovas Ε, Sigala F., Zoga I, Spyridaki K., Papalois A., Papapetropoulos A., Anastasiou-Nana Μ, Kremastinos D. T., Iliodromitis Ε . Short-term statin administration in hypercholesterolemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase and nitro-oxidative stress. Cardiovasc Res: 2012; 94 501 509
51. Andreadou I., Iliodromitis E. K., Tsovolas K., Aggeli I. K., Zoga A., Gaitanaki C., Markantonis S., Beis I., Kremastinos D. T. Acute administration of vitamin E triggers preconditioning via KATP channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radic Biol Med: 2006; 41 1092 1099
52. Bibli S. I., Andreadou I., Lazaris E., Zoga A., Varnavas V., Andreou C. C., Dagres N., Iliodromitis E. K., Kyriakides Z. S. Myocardial protection provided by chronic skeletal muscle ischemia is not further enhanced by ischemic pre- or post-conditioning: comparative effects on intracellular signalling. J Cardiovasc Pharmacol Ther: 2014; 19 220 227
53. Senn H., Schlotterbeck G. NMR spectroscopy techniques for application to metabonomics. In: Lindon J. C., Nicholson J. K., Holmes E. editors The handbook of metabonomics and metabolomics. Amsterdam Elsevier: 2007; 55 112
54. 1H NMR-based metabonomic investigation of the effect of two different exercise sessions on the metabolic fingerprint of human urine. J Proteome Res: 2010; 9 6405 6416
55. 1H NMR metabolomics. Anal Chem: 2006; 78 4281 4290
56. Xia J., Wishart D. S. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc: 2011; 6 743 760